Skip to main content
Clinical Trials/RBR-9hpwgjy
RBR-9hpwgjy
Recruiting
未知

Brain Biomarkers as Response Predictors to Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: development of a paradigm towards personalized medicine

Instituto de Psiquiatria0 sitesMarch 15, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Obsessive-Compulsive Disorder with predominance of obsessive ideas or ruminations
Sponsor
Instituto de Psiquiatria
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 15, 2022
End Date
January 31, 2024
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Instituto de Psiquiatria

Eligibility Criteria

Inclusion Criteria

  • Male or female aged between 18 and 50 years; Main diagnosis of Obsessive\-Compulsive Disorder according to DSM\-5; Y\-BOCS score \= 16; No psychotropic medication used in the last 6 weeks; No behavioral therapy or response prevention exposure focusing on Obsessive\-Compulsive Disorder in the past 6 weeks; Able to tolerate a 1\-week treatment\-free period; and Able to provide informed consent.

Exclusion Criteria

  • Lifetime diagnosis of psychotic disorder, bipolar disorder, anorexia nervosa, autistic spectrum disorder with IQ\<80, Tourette's disorder; Current chronic tic disorder (current \= within the last 12 months); Disorders related to the use of current substances, including nicotine (current \= within the last 12 months); Current eating disorder or bulimia (current \= within the last 12 months); Acute risk of suicide. Pregnant women; Medical or neurological problems (including head trauma with loss of consciousness); Presence of metal devices on the body or dental appliances; IQ\<80; Cigarette use: more than 5 per day; Alcohol use: more than 2 drinks a day for women
  • and more than 3 drinks a day for men; Cannabis use: more than once a week.

Outcomes

Primary Outcomes

Not specified

Similar Trials